More Articles
Medtronic has added a new device, the Penditure Left Atrial Appendage (LAA) Exclusion System, to its cardiac surgery portfolio. The device was designed for the exclusion of the LAA in patients undergoing concomitant heart surgeries, a…
Bayer has ended a clinical trial for its new atrial fibrillation (AFib) drug much earlier than planned based on recommendations from the Independent Data Monitoring Committee (IDMC).…
The U.S. Food and Drug Administration (FDA) has announced that Arrow International, a subsidiary of Teleflex, is recalling nearly 2,000 Pressure Injectable Catheter Kits. The FDA considered this a…
Stanley Capital Partners, a London-based private equity firm, announced that Laboratoire X.O (LXO), its French portfolio company, has acquired a prescription drug for bleeding stroke patients from…
Using intravascular ultrasound (IVUS) to guide percutaneous coronary intervention (PCI) procedures is associated with a significant improvement in survival after two years, according to new findings published in JSCAI, the…
Toku, a New Zealand-based medical device company focused on retinal imaging technology, has received a breakthrough device…
The Mediterranean and…
HeartPoint Global, a Florida-based healthcare technology company focused on improving patient access to high-quality technology, won the Shark Take Innovation Competition at TCT 2023 with its Intellistent multi-lumen stent system. The…
The second round of late-breaking clinical trials at TCT 2023 in San Francisco included updates on two technologies that could reshape the very future of…
Shockwave Medical, the California-based healthcare technology company known for its intravascular lithotripsy (IVL) technology, will be displaying its newest catheter at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 meeting…
Radial access (RA) provides interventional cardiologists with a safe and effective alternative to femoral access during peripheral artery…
A group of interventional cardiology and vascular surgery experts has successfully petitioned the Centers for Medicare and Medicaid Services (CMS) to change its national coverage determination (NCD) for carotid…
Patient-related factors such as diabetes, neurological conditions or a left ventricle ejection fraction (LVEF) less than 50% are all associated with an increased stroke risk after…
Cordis has finalized its agreement to acquire MedAlliance, a Switzerland-based healthcare technology company focused on drug-eluting balloons, in a deal that could potentially be worth more than $1 billion.
…
Patients with cannabis use disorder (CUD) face a heightened risk of adverse cardiovascular events, according to new data published in Addiction.[1]
“Mounting epidemiological, clinical and…
Cardiologists are often not too concerned when atrial arrhythmias occur during the 90-day “blanking period” after catheter ablation. According to a new analysis published in JACC: Clinical Electrophysiology, however, such…
Cardiologists may want to consider bivalirudin over heparin for anticoagulation when non–ST–elevation myocardial infarction (NSTEMI) patients undergo percutaneous coronary intervention (PCI), according to a new meta-analysis published…
Prescribing warfarin to patients after transcatheter aortic valve replacement (TAVR) is not associated with statistically significant…
Surgeons with the University of Maryland Medical Center (UMMC) in Baltimore have transplanted a genetically modified pig heart into a 58-year-old patient facing near-certain death from…
Non-vitamin K oral anticoagulants (NOACs) are associated with fewer major bleeding events and deaths than vitamin K antagonists (VKAs) when treating patients who develop new-onset atrial fibrillation (AFib) after…
When patients with severe aortic stenosis (AS) and coronary artery disease (CAD) are treated with transcatheter aortic valve replacement (TAVR…